Therapy-related Myelodysplastic Syndrome after Autologous Stem Cell Transplantation Using Plerixafor for Mobilized Stem Cells in a Patient with Multiple Myeloma

Схожие документы

• Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario
  по: Kouroukis, C.T., et al.
  Опубликовано: (2016)
• Use of Plerixafor for Stem Cell Mobilization in the Setting of Autologous and Allogeneic Stem Cell Transplantations: An Update
  по: Bilgin, Yavuz M
  Опубликовано: (2021)
• Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma Patients
  по: Moreb, Jan S., et al.
  Опубликовано: (2011)
• Plerixafor for autologous CD34(+) cell mobilization
  по: Salman, Huda, et al.
  Опубликовано: (2011)
• Does use of biosimilar G-CSF change plerixafor utilization during stem cell mobilization for autologous stem cell transplant?
  по: Abdallah, Nadine, et al.
  Опубликовано: (2019)